Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis.

Saved in:
Bibliographic Details
Title: Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis.
Authors: Riedell PA; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Grady CB; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania and Abramson Cancer Center, Philadelphia, PA., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Luna A; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplantation Unit, Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain., Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS., Maziarz RT; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Hu M; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN., Brower J; Center for Cell Therapy and Transplant, University of Pennsylvania and Abramson Cancer Center, Philadelphia, PA., Hwang WT; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania and Abramson Cancer Center, Philadelphia, PA., Schuster SJ; Center for Cell Therapy and Transplant, University of Pennsylvania and Abramson Cancer Center, Philadelphia, PA., Chen AI; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Oluwole OO; Division of Hematology Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN., Bachanova V; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN., McGurik JP; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS., Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Bishop MR; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Porter DL; Center for Cell Therapy and Transplant, University of Pennsylvania and Abramson Cancer Center, Philadelphia, PA.
Source: Blood advances [Blood Adv] 2025 Mar 11; Vol. 9 (5), pp. 1232-1241.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2024014164